Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;8(3):321-9.
doi: 10.1007/s12072-014-9539-3. Epub 2014 Jun 3.

Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma

Affiliations

Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma

Ivonne Nel et al. Hepatol Int. 2014 Jul.

Abstract

Circulating tumor cells (CTC) and cancer stem cells (CSC) have been proposed as tools for detection and characterization of disease and individualization of therapy in patients with many solid tumors. Several automated and semi-automated techniques for identification and isolation of these cells from blood have been proposed and reviewed mostly focusing on their feasibility. In this mini review we summarize the recent relevant literature on this topic and discuss the clinical usability of measuring CTC and CSC in peripheral blood in patients with hepatocellular carcinoma (HCC). Besides literature, the basis for this evaluation was the authors' experience with treating HCC and research experience on CSC and CTC. Few original reports and reviews have been published focusing on CTC and CSC in HCC. Though HCC is one of the five most common malignancies worldwide only recently these cells have come into focus for detection and characterization of this disease that is characterized by high plasticity and malignancy. A focused and prospective validation of the clinical usability of detecting these cells in HCC is still needed, but results seem promising that they may add great benefit for early detection and individualization of therapy.

Keywords: Cancer stem cells; Circulating tumor cells; Hepatocellular carcinoma; Local ablative therapy; Resistance; Systemic therapy.

PubMed Disclaimer

References

    1. Int J Hepatol. 2012;2012:684802 - PubMed
    1. Hepatology. 2011 Mar;53(3):1020-2 - PubMed
    1. Int J Clin Pharmacol Ther. 2014 Jan;52(1):74-5 - PubMed
    1. Cancer Res. 2012 May 15;72(10):2683-91 - PubMed
    1. J Thorac Oncol. 2012 Feb;7(2):306-15 - PubMed

LinkOut - more resources